A tissue selective rapamycin analog inhibits MDA-MB-231 breast cancer cell-induced osteolytic bone metastases in nude mice

被引：0
|
作者：
Metcalf, Chester, III
Boyce, Brendan
Lu, Yan
Xing, Lianping
Zou, Dong
Thomas, Mathew
Rivera, Victor
Berk, Lori
Narasimhan, Narayana
Snodgrass, Joseph
Reid, Noel
Wang, Frank
Wardwell, Scott
Weigele, Manfred
Bedrosian, Camille
Iuliucci, John
Sawyer, Tomi
Clackson, Tim
机构：
[1] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4857
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Treatment of osteolytic lesions in nude rats induced by MDA-MB-231 human breast cancer cells with an antibody against bone sialoprotein
    不详
    CLINICAL & EXPERIMENTAL METASTASIS, 2004, 21 (07) : 605 - 606
  • [2] Treatment of bone metastasis in nude rats induced by MDA-MB-231 human breast cancer cells
    Bäuerle, T
    Berger, MR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1597 - 1597
  • [3] MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: A new rationale for the pathogenesis of osteolytic bone metastases
    Lemma, Silvia
    Di Pompo, Gemma
    Porporato, Paolo E.
    Sboarina, Martina
    Russell, Shonagh
    Gillies, Robert J.
    Baldini, Nicola
    Sonveaux, Pierre
    Avnet, Sofia
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (12): : 3254 - 3264
  • [4] Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice
    Hiroaki Nakamura
    Toru Hiraga
    Tadashi Ninomiya
    Akihiro Hosoya
    Noboru Fujisaki
    Toshiyuki Yoneda
    Hidehiro Ozawa
    Journal of Bone and Mineral Metabolism, 2008, 26 : 642 - 647
  • [5] Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice
    Nakamura, Hiroaki
    Hiraga, Toru
    Ninomiya, Tadashi
    Hosoya, Akihiro
    Fujisaki, Noboru
    Yoneda, Toshiyuki
    Ozawa, Hidehiro
    JOURNAL OF BONE AND MINERAL METABOLISM, 2008, 26 (06) : 642 - 647
  • [6] Unexpected Preferential Brain Metastases with a Human Breast Tumor Cell Line MDA-MB-231 in BALB/c Nude Mice
    El-Mabhouh, A. A.
    Nation, P. N.
    Kaddoura, A.
    Mercer, J. R.
    VETERINARY PATHOLOGY, 2008, 45 (06) : 941 - 944
  • [7] Dehydrocorydaline inhibits the tumorigenesis of breast cancer MDA-MB-231 cells
    Huang, Ying
    Huang, Hui
    Wang, Shiying
    Chen, Feixiang
    Zheng, Gang
    MOLECULAR MEDICINE REPORTS, 2020, 22 (01) : 43 - 50
  • [8] Rat monoclonal antibodies against bone sialoprotein II inhibit tumor growth and osteolytic lesions in nude rats induced by MDA-MB-231 breast cancer cells
    Zepp, M.
    Armbruster, F. P.
    Berger, M. R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (07) : 462 - 464
  • [9] Ibandronate treatment induces remission of established osteolytic lesions in a nude rat model of human breast cancer (MDA-MB-231).
    Neudert, M
    Fischer, C
    Krempien, B
    Bauss, F
    Seibel, MJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S351 - S351
  • [10] A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice
    Lee, J
    Weber, M
    Mejia, S
    Bone, E
    Watson, P
    Orr, W
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (01) : 106 - 113
12345